Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

reNEW, the Novo Nordisk Foundation Center for Stem Cell Medicine, was launched in January 2022 and it supports stem cell research across three international sites in Denmark, Australia ...

Stock prices in London opened higher on Monday, with a US Treasury chief pick calming market nerves, while there was a slew of M&A updates among early corporate updates. Bookending the FTSE 100, ...

In early UK corporate news, miner Anglo American and fish farming company Benchmark Holdings announced disposals. DIY retail chain operator Kingfisher trimmed the top of its profit outlook range, as ...

You can tell the recent history of the European economy in two figures. In 1992, adjusting for spending power, a GDP per ...

Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion ...

Novo Nordisk A/S is cutting back on recruiting in Denmark after reaching the limits of its home country’s labor market in the ...

Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...

The world’s largest philanthropic fund that ultimately controls Novo Nordisk A/S will ramp up its investments outside of ...

A Scandinavian economic behemoth, Novo Nordisk is the highest valued company in Europe at over $500 billion, which exceeds Denmark’s entire GDP. Ironically, Ozempic and Wegovy, as with many of ...

Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding ...